CytoSorbents updates financial calendar with Q2 results release, conference call scheduledPUBT·Jul 20 at 06:00 AMCTSO+3.08%
The AI Hangover Is Over: Finding Actual ROI in Tech and FintechGlobal Report·Jul 7 at 05:38 AMPATH+2.30%ZETA+1.24%
CytoSorbents gets Nasdaq notice for falling below $35 million market value thresholdPUBT·Jul 6 at 03:06 PMCTSO+3.08%
CytoSorbents posts investor presentation outlining blood purification products, DrugSorb-ATR regulatory pathPUBT·Jun 25 at 08:28 AMCTSO+3.08%FMS-0.21%
CytoSorbents CEO to present at Virtual Investor Conferences Life Sciences ForumPUBT·Jun 18 at 07:46 AMCTSO+3.08%
Transcript: CytoSorbents Q1 2026 Earnings Conference Callbenzinga_article·May 13 at 04:36 PMCTSO+3.08%
CytoSorbents | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 8.864 MEarnings Watch·May 13 at 03:29 PMCTSO+3.08%
CytoSorbents | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 8.864 MEarnings Watch·May 13 at 03:11 PMCTSO+3.08%
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | CTSO Stock NewsStockTitan·May 13 at 07:00 AMCTSO+3.08%
